Nevertheless, results shown here depicted a new layer of regulation in control of tumor glutamine metabolism and provided a molecular explanation for the functional significance of GLS2 overexpression observed in MYCN-amplified neuroblastomas. The gene discussed is MYCN; the disease is neuroblastoma.